Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Doxofylline (650mg) SR
Therapeutic Category
Asthma, General and OTC medicines, Pulmonary, Respiratory
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹199/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Dozyfyle 650 SR Tablet is a bronchodilator formulated for the effective management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It contains Doxofylline, a xanthine derivative with potent anti-inflammatory and bronchodilatory properties. Doxofylline works by relaxing the smooth muscles of the airway and reducing inflammation, thereby improving airflow to the lungs.
The sustained-release formulation ensures a prolonged therapeutic effect, reducing the frequency of dosing and maintaining consistent relief from symptoms such as wheezing, shortness of breath, and chest tightness. Dozyfyle 650 SR is well-tolerated and has a lower risk of cardiovascular side effects compared to other xanthines, making it a preferred choice for long-term respiratory care.
This medication helps improve lung function and enhances the quality of life for individuals with chronic respiratory conditions, enabling them to lead more active lives with reduced breathlessness and improved exercise tolerance.
Common side effects include headache, nausea, dizziness, and gastrointestinal discomfort. Rarely, patients may experience palpitations or restlessness. If severe or persistent side effects occur, seek medical advice.
Dozyfyle 650 SR Tablet is indicated for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions involving airway obstruction and inflammation.
Use this medication under the supervision of a healthcare provider. Do not exceed the prescribed dosage, and avoid combining with other xanthine derivatives without medical advice.
Store in a cool, dry place away from direct sunlight and moisture. Keep out of the reach of children.
Composition : Doxofylline (400mg) + Montelukast (10mg)
Composition : Doxofylline (400mg)
Composition : Doxofylline (400mg) + Ambroxol (30mg)
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Salmeterol (50mcg) + Fluticasone Propionate (500 mcg)
Composition : Levosalbutamol (100mcg) + Ipratropium (80mcg)
Composition : Levosalbutamol (50mcg) + Ipratropium (20mcg)
Composition : Tiotropium (9mcg)
Composition : Formoterol (12mcg) + Tiotropium (18mcg)
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Doxofylline 650mg SR Tablet is a high-strength respiratory medicine used in chronic airway diseases, making it a strong prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in asthma, COPD (chronic obstructive pulmonary disease), chronic bronchitis, wheezing, and long-term respiratory obstruction cases. It is widely prescribed by pulmonologists and general physicians for maintenance therapy.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Doxofylline 650mg SR Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong chronic prescription demand, long-term patient therapy cycles, and steady seasonal respiratory sales when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this respiratory formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.